Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1372254 | Bioorganic & Medicinal Chemistry Letters | 2009 | 5 Pages |
Human rhinovirus 3C protease (HRV 3Cpro) is known to be a promising target for development of therapeutic agents against the common cold because of the importance of the protease in viral replication as well as its expression in a large number of serotypes. To explore non-peptidic inhibitors of HRV 3Cpro, a series of novel heteroaromatic esters was synthesized and evaluated for inhibitory activity against HRV 3Cpro, to determine the structure–activity relationships. The most potent inhibitor, 7, with a 5-bromopyridinyl group, had an IC50 value of 80 nM. In addition, the binding mode of a novel analog, 19, with the 4-hydroxyquinolinone moiety, was explored by molecular docking, suggesting a new interaction in the S1 pocket.
Graphical abstractThe non-peptidic inhibitors against HRV 3C protease, a series of novel heteroaromatic esters were synthesized and evaluated their activity.Figure optionsDownload full-size imageDownload as PowerPoint slide